Skip to content
Screener

Bio-Rad Laboratories BIO Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$990.7M+21.3%
BioLife Solutions logo
BioLife SolutionsBLFS
$7.08M-58.9%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
Agilent Technologies logo
Agilent TechnologiesA
Labcorp Holdings logo
Labcorp HoldingsLH

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$9.42B+31.8%
Enterprise value$9.9B+20.9%
P/E55.8×+33.4×
P/S3.6×+0.8×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000012208-26-000035
Line itemWeighted-Average Amortization Period (in years)Purchase PriceAccumulated AmortizationNet Carrying Amount
Customer relationships/lists4.2$114.7$(107.3)$7.4
Developed product technology10.5313.2(163.4)149.8
Licenses2.959.6(50.9)8.7
Tradenames3.36.0(5.2)0.8
Covenants not to compete0.26.5(6.4)0.1
Total purchased intangible assets$500.0$(333.2)$166.8

Item 1. Financial Statements (Unaudited)

FAQ

What is Bio-Rad Laboratories's finite-lived intangible assets, accumulated amortization?
Bio-Rad Laboratories (BIO) reported finite-lived intangible assets, accumulated amortization of $333.2M in Q1 2026.
How has Bio-Rad Laboratories's finite-lived intangible assets, accumulated amortization changed year-over-year?
Bio-Rad Laboratories's finite-lived intangible assets, accumulated amortization decreased by 28.5% year-over-year, from $465.9M to $333.2M.
What is the long-term trend for Bio-Rad Laboratories's finite-lived intangible assets, accumulated amortization?
Over 5 years (2020 to 2025), Bio-Rad Laboratories's finite-lived intangible assets, accumulated amortization has grown at a -4.4% compound annual growth rate (CAGR), from $413.4M to $329.4M.

Ask your AI about Bio-Rad Laboratories's finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude